Total Funding
54
2
Total FundingPost-IPO Equity raised
Growth Score
-6 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3125783
Teligent is a specialty generic pharmaceutical company.
Ernest R. De Paolantonio: CFO Teligent Inc.Past Role: BioDelivery Sciences, CFO
Timothy Sawyer: Chief Executive Officer & President
About the Company
Teligent develop, manufacture and market pharmaceutical products for use by doctors and patients in the United States and Canada.
They are a dynamic group of about 130 employees based in New Jersey, Toronto, Montreal and Tallinn, Estonia. Their Product Development and Manufacturing complex is in Buena, New Jersey, approximately 45 minutes from
Philadelphia. In 2015 They acquired Alveda Pharmaceuticals Inc., a Toronto-based pharmaceutical company focused on the Canadian injectable pharmaceutical market. In 2016 They hired Their first European colleagues in Tallinn who support Their supply chain and quality operations.
